GlaxoSmithKline to name Sir Philip Hampton chair September 24, 2014 SHARES in pharmaceutical giant GlaxoSmithKline (GSK) rose slightly in late afternoon trading yesterday after it emerged that Sir Philip Hampton was likely to be named as its new chairman. GSK is likely to announce Hampton’s move in the next two days – and with such a large job he is expected to eventually give up [...]
Share price up after rumours RBS’ Sir Philip Hampton “will be named GSK chairman before the weekend” September 24, 2014 Shares in pharmaceutical giant GlaxoSmithKline rose slightly in late afternoon trading after it emerged Sir Philip Hampton is likely to be named as its new chairman. Shares climbed 0.2 per cent to 1,425p, having spent the afternoon around the 1,418p mark. GSK is likely to announce Hampton's move in the next two days – such [...]
GSK share price shows immunity to Ebola vaccine September 17, 2014 The news GSK’s Ebola vaccine is to be trialled on humans failed to lift the company on the stock market this morning, with its share price falling 0.21 per cent to 1,438 pence. The experimental vaccine is to be tested on 60 healthy adults in Oxford, after it conferred resistance on a group of [...]
GSK share price falls, despite Ebola vaccine success September 8, 2014 Monkeys given an experimental Ebola vaccine developed by GSK were resistant to the deadly virus when infected with it five weeks later, trials have shown. The results of a drug trial, published in the journal Nature, show all of the monkeys not given the vaccine died within 6 days of infection, whereas the four [...]
GSK Ebola vaccine to be tested in UK August 28, 2014 An international consortium is fast-tracking an Ebola vaccine under development by the US National Institutes of Health (NIH) and GlaxoSmithKline, with human trials set to begin in the UK as early as September. The move follows a declaration by the World Health Organisation (WHO) that the Ebola outbreak in West Africa is a public [...]
GlaxoSmithKline to investigate fresh bribery claims in Syria August 12, 2014 GlaxoSmithKline is facing new bribery allegations in Syria, the latest in a string of accusations flung at the drugmaker from countries across the world. The FTSE 100-quoted company is accused of bribing Syrian doctors and officials to boost sales of its medicines, by offering cash, trips and free medical samples. The latest claims emerged after [...]
RBS chairman Sir Philip Hampton mulls move to head GlaxoSmithKline August 8, 2014 Sir Philip Hampton could jump ship to leading pharmaceutical firm GlaxoSmithKline after six years chairing RBS, it was reported yesterday. Neither is in any rush to replace its chairman – Glaxo’s chair Sir Christopher Gent expects to serve at the firm until the end of next year. He has served at the company for a [...]
Philip Hampton is being lined up to replace Sir Christopher Gent as GSK’s next chairman August 7, 2014 Sir Philip Hampton is being lined up to take the role of chairman at Britain’s biggest drug company Glaxosmithkline after exiting Royal Bank of Scotland, Sky News reports. It’s said that Hampton will join GSK as early as next month as a non-executive director or deputy chairman, moving into the chairman’s seat by 2015. GSK’s [...]
GSK says separate consumer business is possible July 27, 2014 The chief executive of GlaxoSmithKline has said that he is open to the idea of creating a breakaway consumer healthcare business, the FT reports. Sir Andrew Witty said that a breakup of the group would be reasonable if a time came when a standalone consumer business offered more value. He said that his [...]
GSK seeks regulatory approval for the first ever malaria vaccine July 24, 2014 British drugmaker GlaxoSmithKline (GSK) has developed the world's first anti-malaria vaccine, designed for use on children in Africa. If GSK acquires the regulatory approval it is currently seeking, it will mark a big step forward in the fight against the mosquito-borne parasitic disease, which currently kills over 600,000 people a year. Most of [...]